B.L. Scott

7.4k total citations
47 papers, 2.2k citations indexed

About

B.L. Scott is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, B.L. Scott has authored 47 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Neurology, 16 papers in Cellular and Molecular Neuroscience and 13 papers in Molecular Biology. Recurrent topics in B.L. Scott's work include Parkinson's Disease Mechanisms and Treatments (19 papers), Neurological disorders and treatments (13 papers) and Botulinum Toxin and Related Neurological Disorders (9 papers). B.L. Scott is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (19 papers), Neurological disorders and treatments (13 papers) and Botulinum Toxin and Related Neurological Disorders (9 papers). B.L. Scott collaborates with scholars based in United States, Singapore and United Kingdom. B.L. Scott's co-authors include Nicolás G. Bazán, Jeffery M. Vance, Joseph Jankovic, William K. Scott, Jeffrey M. Stajich, Eden R. Martin, Mark Stacy, Dana B. Hancock, Gregory M. Mayhew and Michael A. Hauser and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

B.L. Scott

47 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.L. Scott United States 20 1.0k 760 543 340 311 47 2.2k
Victoria Trembovler Israel 31 796 0.8× 972 1.3× 599 1.1× 89 0.3× 461 1.5× 61 2.9k
Chunjiu Zhong China 25 811 0.8× 823 1.1× 357 0.7× 200 0.6× 918 3.0× 61 2.8k
James G. Greene United States 25 923 0.9× 949 1.2× 1.0k 1.9× 91 0.3× 628 2.0× 46 2.5k
Josefina Cano Spain 26 647 0.6× 865 1.1× 1.0k 1.9× 163 0.5× 399 1.3× 60 2.6k
Fulvio Marzatico Italy 31 521 0.5× 976 1.3× 328 0.6× 237 0.7× 783 2.5× 107 2.7k
Walter Balduini Italy 31 298 0.3× 1.1k 1.5× 576 1.1× 127 0.4× 343 1.1× 100 3.4k
Asako Yoritaka Japan 20 1.2k 1.1× 690 0.9× 584 1.1× 79 0.2× 436 1.4× 48 2.2k
Christopher van Dyck United States 13 574 0.6× 277 0.4× 454 0.8× 287 0.8× 590 1.9× 30 1.9k
Gail D. Zeevalk United States 25 497 0.5× 741 1.0× 919 1.7× 68 0.2× 228 0.7× 47 1.8k
Anmu Xie China 25 743 0.7× 723 1.0× 397 0.7× 143 0.4× 407 1.3× 99 2.1k

Countries citing papers authored by B.L. Scott

Since Specialization
Citations

This map shows the geographic impact of B.L. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.L. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.L. Scott more than expected).

Fields of papers citing papers by B.L. Scott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.L. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.L. Scott. The network helps show where B.L. Scott may publish in the future.

Co-authorship network of co-authors of B.L. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of B.L. Scott. A scholar is included among the top collaborators of B.L. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.L. Scott. B.L. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richardson, Alexander, Ricardo Henao, Terry Lee, et al.. (2024). A Convolutional Neural Network to Identify Parkinson’s Disease using Multimodal Retinal Images. Alzheimer s & Dementia. 20(S2). 1 indexed citations
3.
Robbins, Cason B., Rupesh Agrawal, Sandra S. Stinnett, et al.. (2023). Longitudinal Analysis of Retinal Microvascular and Choroidal Imaging Parameters in Parkinson's Disease Compared with Controls. SHILAP Revista de lepidopterología. 3(4). 100393–100393. 9 indexed citations
4.
Bukhari‐Parlakturk, Noreen, Michael W. Lutz, Hussein R. Al‐Khalidi, et al.. (2022). Suitability of Automated Writing Measures for Clinical Trial Outcome in Writer's Cramp. Movement Disorders. 38(1). 123–132. 3 indexed citations
5.
Robbins, Cason B., Sarah McGrory, Dilraj S. Grewal, et al.. (2021). Retinal vascular changes in Parkinson’s disease on ultra-widefield retinal imaging. Investigative Ophthalmology & Visual Science. 62(8). 1779–1779. 1 indexed citations
6.
Robbins, Cason B., Dilraj S. Grewal, Atalie C. Thompson, et al.. (2021). Identifying Peripapillary Radial Capillary Plexus Alterations in Parkinson’s Disease Using OCT Angiography. Ophthalmology Retina. 6(1). 29–36. 23 indexed citations
7.
Robbins, Cason B., Sandra S. Stinnett, Kim G. Johnson, et al.. (2021). Repeatability of Peripapillary OCT Angiography in Neurodegenerative Disease. SHILAP Revista de lepidopterología. 1(4). 100075–100075. 10 indexed citations
8.
Edwards, Todd L., William K. Scott, Amber Burt, et al.. (2010). Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease. Annals of Human Genetics. 74(2). 97–109. 370 indexed citations
9.
Edwards, Christopher L., et al.. (2010). Integrated Behavior Therapy in the Treatment of Complicated Tourette’s Disorder and Its Comorbidities. Clinical Case Studies. 9(2). 154–163. 3 indexed citations
10.
Wingo, Thomas S., Marian L. Evatt, B.L. Scott, Alan Freeman, & Mark Stacy. (2008). Impulse Control Disorders Arising in 3 Patients Treated With Rotigotine. Clinical Neuropharmacology. 32(2). 59–62. 24 indexed citations
11.
Hancock, Dana B., Eden R. Martin, Gregory M. Mayhew, et al.. (2008). Pesticide exposure and risk of Parkinson's disease: A family-based case-control study. BMC Neurology. 8(1). 6–6. 215 indexed citations
12.
Hancock, Dana B., Eden R. Martin, Jeffrey M. Stajich, et al.. (2007). Smoking, Caffeine, and Nonsteroidal Anti-inflammatory Drugs in Families With Parkinson Disease. Archives of Neurology. 64(4). 576–576. 85 indexed citations
13.
Hauser, Michael A., Yi‐Ju Li, Hong Xu, et al.. (2005). Expression Profiling of Substantia Nigra in Parkinson Disease, Progressive Supranuclear Palsy, and Frontotemporal Dementia With Parkinsonism. Archives of Neurology. 62(6). 917–21. 129 indexed citations
14.
Walt, Joelle M. van der, Maher Noureddine, Raja Kittappa, et al.. (2004). Fibroblast Growth Factor 20 Polymorphisms and Haplotypes Strongly Influence Risk of Parkinson Disease. The American Journal of Human Genetics. 74(6). 1121–1127. 106 indexed citations
15.
Scott, B.L., et al.. (2003). A case of combined orthostatic tremor and primary gait ignition failure. Clinical Neurology and Neurosurgery. 105(4). 277–280. 2 indexed citations
16.
Palmer, Cynthia S., et al.. (2000). Patient preferences and utilities for ‘off-time’ outcomes in the treatment of Parkinson's disease. Quality of Life Research. 9(7). 819–827. 45 indexed citations
17.
Scott, B.L., et al.. (1998). Human apolipoprotein E accelerates microtubule polymerization in vitro. Neuroscience Letters. 245(2). 105–108. 12 indexed citations
18.
Scott, B.L. & Joseph Jankovic. (1996). Delayed-onset progressive movement disorders after static brain lesions. Neurology. 46(1). 68–74. 125 indexed citations
19.
Corless, Joseph M., Darrell R. McCaslin, & B.L. Scott. (1982). Two-dimensional rhodopsin crystals from disk membranes of frog retinal rod outer segments.. Proceedings of the National Academy of Sciences. 79(4). 1116–1120. 60 indexed citations
20.
Gitter, Kurt A., et al.. (1978). Dominantly Inherited Peripheral Retinal Neovascularization. Archives of Ophthalmology. 96(9). 1601–1605. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026